Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer

Conditions

• Lung Cancer

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• cisplatin — DRUG
• etoposide — DRUG
• hydroxyurea — DRUG
• vinblastine sulfate — DRUG
• vindesine — DRUG
• vinorelbine tartrate — DRUG
• drug resistance inhibition treatment — PROCEDURE

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug is a way to kill more tumor cells. PURPOSE: Phase I trial to study the effects of hydroxyurea plus combination chemotherapy in patients with non-small cell lung cancer.

Key Dates

First listed

Mar 26, 2004

Start date

Jul 31, 1995

Status verified

Oct 2001

Study Design

Enrollment

30 participants (estimated)

Primary purpose

TREATMENT

Find similar trials

Related Studies

• Evaluation for NCI Surgery Branch Clinical Research Protocols
  Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
• Collection of Blood From Patients With Cancer
  Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
• Detection of Genetic Markers of Lung Cancer
  Recruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
• Lung Cancer Biomarkers and Screening
  Recruiting · NYU Langone Health · New York, New York